Aligos Therapeutics to Present at the Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. June 2, 2020 – Aligos Therapeutics, Inc., a private biotechnology company focused on the development of targeted, antiviral therapies including chronic hepatitis B (CHB) and COVID-19 as well as therapeutics for NASH, today announced that Lawrence Blatt, Ph.D., MBA , Chief Executive Officer of Aligos, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020 at 1:30 p.m. Eastern Time.
Jefferies Virtual Healthcare Conference
Date: Thursday, June 4th, 2020
Time: 1:30 pm Eastern Time
Webcast: http://wsw.com/webcast/jeff126/alig/
About Jefferies Virtual Healthcare Conference
The format will include video & audio company presentations, interactive panels, and 1×1 meetings conducted via organized conference calls. This virtual gathering of over 400 public & private healthcare companies and 2,500 leading executives, institutional investors, private equity investors & VCs will address near- and long-term investment opportunities and discuss the current mechanisms driving healthcare in the U.S. and internationally.
For further information, please visit: www.Jefferies.com/Conferences
